Literature DB >> 27788390

Inflammation versus mechanical stretch biomarkers over time in acutely decompensated heart failure with reduced ejection fraction.

M Boulogne1, M Sadoune2, J M Launay3, M Baudet1, A Cohen-Solal4, D Logeart5.   

Abstract

Heart failure can be associated with inflammation but it is unclear if inflammation is directly related to hemodynamic worsening or is an independent pathway. Our aim was to investigate inflammation and mechanical stress using serial measurements of biomarkers in acute and chronic heart failure with reduced ejection fraction (AHF and CHF).
METHOD: The following biomarkers were measured on admission, at discharge and one month after discharge: B-type natriuretic peptide (BNP), high-sensitivity C-Reactive protein (hsCRP), Tumour Necrosis Factor alpha (TNFα), interleukin 6 (IL6), myeloperoxidase (MPO), suppression of tumorigenicity 2 (ST2), mid-regional pro-adrenomedullin (MR-proADM), galectin 3 (Gal3), Growth differentiating factor 15 (GDF15) and procalcitonin (PCT).
RESULTS: In control CHF group (n=20, 69±11y, NYHA 1-2), most biomarker levels were low and stable over time. In AHF (n=55, 71±14y), BNP, ST2 and GDF15 levels were highly increased on admission and then decreased rapidly with clinical improvement; BNP, ST2 and GDF15 levels were statistically correlated (r=0.64, 0.46 and 0.39; p<0.001 for both). Both hsCRP, MPO, TNFα and Gal3 levels were increased in most AHF patients (70, 56, 83 and 98% respectively) with poor change over time. HsCRP, MPO and TNFα levels were correlated. IL6, MR-proADM and PCT levels were slightly increased, without change over time. Highest quartiles of BNP and ST2 were associated with death or readmission at one year (HR 2.33 [95CI 1.13-4.80] and 2.42 [1.27-4.60]).
CONCLUSION: AHF is associated with systemic inflammation. This inflammatory response continued up to one month after discharge despite normalisation of mechanical stress-related markers. Copyright Â
© 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Biomarkers; Heart failure; Inflammation

Mesh:

Substances:

Year:  2016        PMID: 27788390     DOI: 10.1016/j.ijcard.2016.10.038

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  21 in total

Review 1.  Biomarkers in heart failure: the past, current and future.

Authors:  Michael Sarhene; Yili Wang; Jing Wei; Yuting Huang; Min Li; Lan Li; Enoch Acheampong; Zhou Zhengcan; Qin Xiaoyan; Xu Yunsheng; Mao Jingyuan; Gao Xiumei; Fan Guanwei
Journal:  Heart Fail Rev       Date:  2019-11       Impact factor: 4.214

Review 2.  Reappraisal of Inflammatory Biomarkers in Heart Failure.

Authors:  Thanat Chaikijurajai; W H Wilson Tang
Journal:  Curr Heart Fail Rep       Date:  2020-02

3.  Specific biomarkers of myocardial inflammation and remodeling processes as predictors of mortality in high-risk patients undergoing percutaneous mitral valve repair (MitraClip).

Authors:  Oliver Dörr; Claudia Walther; Christoph Liebetrau; Till Keller; Hannes Tabert; Niklas Boeder; Matthias Bayer; Pascal Bauer; Helge Möllmann; Luise Gaede; Christian Troidl; Sandra Voss; Timm Bauer; Christian W Hamm; Holger Nef
Journal:  Clin Cardiol       Date:  2018-04-17       Impact factor: 2.882

4.  Tumor necrosis factor-α levels and non-surgical bleeding in continuous-flow left ventricular assist devices.

Authors:  Corey E Tabit; Mitchell J Coplan; Phetcharat Chen; Valluvan Jeevanandam; Nir Uriel; James K Liao
Journal:  J Heart Lung Transplant       Date:  2017-06-08       Impact factor: 10.247

5.  A New Biomarker Tool for Risk Stratification in "de novo" Acute Heart Failure (OROME).

Authors:  Rosa M Agra-Bermejo; Carla Cacho-Antonio; Eva Gonzalez-Babarro; Adriana Rozados-Luis; Marinela Couselo-Seijas; Inés Gómez-Otero; Alfonso Varela-Román; José N López-Canoa; Isabel Gómez-Rodríguez; María Pata; Sonia Eiras; Jose R González-Juanatey
Journal:  Front Physiol       Date:  2022-01-13       Impact factor: 4.566

Review 6.  Multidimensional Approach of Heart Failure Diagnosis and Prognostication Utilizing Cardiac Imaging with Biomarkers.

Authors:  In-Cheol Kim; Byung-Su Yoo
Journal:  Diagnostics (Basel)       Date:  2022-06-01

Review 7.  GDF-15 as a Biomarker in Cardiovascular Disease.

Authors:  Bruna Miers May; Mauricio Pimentel; Leandro Ioschpe Zimerman; Luis Eduardo Rohde
Journal:  Arq Bras Cardiol       Date:  2021-03       Impact factor: 2.000

Review 8.  The role of procalcitonin in acute heart failure patients.

Authors:  Martin Möckel; Julia Searle; Alan Maisel
Journal:  ESC Heart Fail       Date:  2017-07-18

9.  A Multiparametric Approach Based on NT-proBNP, ST2, and Galectin3 for Stratifying One Year Prognosis of Chronic Heart Failure Outpatients.

Authors:  Dario Grande; Marta Leone; Caterina Rizzo; Paola Terlizzese; Giuseppe Parisi; Margherita Ilaria Gioia; Tiziana Leopizzi; Antonio Segreto; Piero Guida; Roberta Romito; Marco Matteo Ciccone; Francesca Di Serio; Massimo Iacoviello
Journal:  J Cardiovasc Dev Dis       Date:  2017-07-15

Review 10.  From Inflammation to Fibrosis-Molecular and Cellular Mechanisms of Myocardial Tissue Remodelling and Perspectives on Differential Treatment Opportunities.

Authors:  Navin Suthahar; Wouter C Meijers; Herman H W Silljé; Rudolf A de Boer
Journal:  Curr Heart Fail Rep       Date:  2017-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.